7N4-46432-16221 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Registered in v-safe
2020-12-17
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-07
Dose 2 — Pfizer-BioNTech
2021-01-07
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-08
Survey response — days 1–6 daily, dose 2
MedDRA: Headache, Visual field defect — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Free text: Visual field cuts prior to headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Nausea

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-28
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-04
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-08
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-01-09
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Covid +

MedDRA releases: 2024-11 · check-in free text available
2022-01-09
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-11
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-07	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-08	priority 2/3
2022-01-09	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-08

Systemic reaction (other): Visual field cuts prior to headache

Release 10 — 12 months, dose 2

2022-01-09

Symptoms: Covid +

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SRO	Headache	✓	✓	✓
SRO	Visual field defect	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release